Shimadzu Amyloid MS™ Service

For the rapid detection of Alzheimer's Disease in blood Dedicated to Drug Discovery and Development

For the rapid prediction of Alzheimer’s Disease in blood

Dedicated to Drug Discovery and Development


Shimadzu recently developed  Amyloid Mass Spectrometry (MS) Service — a new simple, low-cost blood analysis for early screening of amyloid-positive subjects. This method enables early and accurate prediction of amyloid deposition in the brain with an easy-to-acquire blood sample. 

Unlike conventional methods, Shimadzu’s new analysis is minimally invasive, cost-effective and suitable for large-scale deployment.

It’s the only blood analysis capable of predicting abnormal amyloid-beta deposition in the brain with high accuracy.

For Research Use Only. Not for use in diagnostic procedures.
Amyloid MS Service is for drug discovery and development only.

Shimadzu’s Amyloid MS Service offers…

Amyloid MS Service - Read our e-book
  • Reduced costs per test
  • A less invasive blood-based sampling technique
  • Low sample volume requirements (0.6 mL)
Shimadzu has built an efficient process for analyzing samples:
  1. Samples are collected and shipped to Shimadzu.
  2. Shimadzu analyzes the samples.
  3. Shimadzu sends a detailed report via electronic format.



Top of This Page